Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 26 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Συντάκτης is Doumas, Michael  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Doumas, M., Imprialos K. P., & Stavropoulos K. (2018).  Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.. N Engl J Med. 378(10), 967.
Doumas, M., & Papademetriou V. (2009).  Telmisartan for prevention of cardiovascular events.. N Engl J Med. 360(3), 302; author reply 303.
Doumas, M., Papademetriou V., Faselis C., & Kokkinos P. (2013).  Gender differences in hypertension: myths and reality.. Curr Hypertens Rep. 15(4), 321-30.
Doumas, M., Stavropoulos K., & Imprialos K. (2017).  Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?. J Hypertens. 35(5), 950-952.
Doumas, M., & Douma S. (2010).  Renal sympathetic denervation: the jury is still out.. Lancet. 376(9756), 1878-80.
Doumas, M., Lazaridis A., & Papademetriou V. (2014).  Renal nerve ablation for resistant hypertension: the dust has not yet settled.. J Clin Hypertens (Greenwich). 16(6), 399-400.
Doumas, M., Imprialos K. P., Stavropoulos K., & Athyros V. G. (2018).  Peripheral arterial stiffness as a surrogate of central hemodynamics: A new era for cardiovascular risk estimation?. J Clin Hypertens (Greenwich). 20(3), 469-471.
Doumas, M., Anyfanti P., & Bakris G. (2012).  Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective.. J Hypertens. 30(5), 874-6.
Doumas, M., Papademetriou V., Athyros V., & Karagiannis A. (2015).  Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.. Angiology. 66(10), 901-3.
Doumas, M., Faselis C., & Papademetriou V. (2010).  Renal sympathetic denervation and systemic hypertension.. Am J Cardiol. 105(4), 570-6.
Doumas, M. (2014).  Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?. Curr Vasc Pharmacol. 12(1), 2-3.
Doumas, M., Tsioufis C., Fletcher R., Amdur R., Faselis C., & Papademetriou V. (2017).  Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension.. J Am Heart Assoc. 6(11), 
Doumas, M., Anyfanti P., & Triantafyllou A. (2012).  Management of erectile dysfunction: do not forget hypertension.. Arch Intern Med. 172(7), 597-8; discussion 598.
Doumas, M., Athyros V., & Karagiannis A. (2015).  Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?. Cardiology. 131(3), 186-8.
Doumas, M., Imprialos Κ., Stavropoulos K., Reklou A., Sachinidis A., & Athyros V. G. (2018).  Combination of SGLT-2 inhibitors and GLP-1 receptor agonists: potential benefits in surrogate and hard endpoints.. Curr Pharm Des.
Doumas, M., Guo D., & Papademetriou V. (2009).  Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions.. Expert Opin Ther Targets. 13(4), 413-25.
Doumas, M., Lazaridis A., & Reklou A. (2013).  Effects of hypertension and antihypertensive therapy on sexual function in the elderly: the jury is still out.. J Hypertens. 31(9), 1917-8.
Doumas, M., Katsiki N., & Papademetriou V. (2018).  Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?. Angiology. 69(1), 5-9.
Doumas, M., Faselis C., & Papademetriou V. (2011).  Renal sympathetic denervation in hypertension.. Curr Opin Nephrol Hypertens. 20(6), 647-53.
Doumas, M., Athyros V., & Papademetriou V. (2015).  Screening for Primary Aldosteronism: Whom and How?. J Clin Hypertens (Greenwich). 17(7), 547-8.
Doumas, M., Stavropoulos K., Imprialos K. P., Athyros V. G., & Karagiannis A. (2018).  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?. J Clin Hypertens (Greenwich). 20(4), 634-636.
Doumas, M., & Douma S. (2009).  Interventional management of resistant hypertension.. Lancet. 373(9671), 1228-30.
Doumas, M., Lazaridis A., & Reklou A. (2013).  Masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretations.. Hypertension. 62(4), e21.
Doumas, M., Stavropoulos K. V., Boutari C., Imprialos K. P., & Karagiannis A. (2017).  Blood pressure and cardiovascular outcomes: a closer look.. Lancet. 389(10076), 1295-1296.
Doumas, M., Papademetriou V., Douma S., Faselis C., Tsioufis K., Gkaliagkousi E., et al. (2010).  Benefits from treatment and control of patients with resistant hypertension.. Int J Hypertens. 2011, 318549.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.